Chih-hsiang Leng
Miaoli, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Enhancing cancer vaccine efficacy via electrostatic engineering of an FcγR-targeted protein.
Journal: Frontiers in immunology
Published: March 16, 2026
A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge.
Journal: Emerging microbes & infections
Published: October 19, 2023
Domain 4 of pneumolysin from Streptococcus pneumoniae is a multifunctional domain contributing TLR4 activating and hemolytic activity.
Journal: Biochemical and biophysical research communications
Published: July 12, 2019
Delivery of Antigen to CD8+ Dendritic Cells by Fusing Antigen With Formyl Peptide Receptor-Like 1 Inhibitor Protein Induces Antitumor Immunity.
Journal: Frontiers in immunology
Published: May 25, 2019
A therapeutic vaccine targeting HPV E6/E7 with intrinsic Toll-like receptor 2 agonist activity induces antitumor immunity.
Journal: American journal of cancer research
Published: November 08, 2018
Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity.
Journal: Frontiers in immunology
Published: October 06, 2017
CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responses.
Journal: Scientific reports
Published: July 24, 2017
The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection.
Journal: Human vaccines & immunotherapeutics
Published: February 23, 2016
Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice.
Journal: Scientific reports
Published: February 17, 2016
Last Updated: 09/26/2026